- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/10 - Spiro-condensed systems
Patent holdings for IPC class C07D 498/10
Total number of patents in this class: 937
10-year publication summary
|
33
|
56
|
45
|
56
|
51
|
51
|
72
|
81
|
74
|
73
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3734 |
29 |
| Bristol-myers Squibb Company | 4848 |
26 |
| Amgen Inc. | 4158 |
26 |
| F. Hoffmann-La Roche AG | 7932 |
24 |
| Novartis AG | 10656 |
22 |
| Hoffmann-La Roche Inc. | 3516 |
22 |
| Boehringer Ingelheim International GmbH | 4648 |
22 |
| Janssen Pharmaceutica N.V. | 3349 |
21 |
| Vertex Pharmaceuticals Incorporated | 1623 |
18 |
| Arvinas Operations, Inc. | 242 |
18 |
| Merck Patent GmbH | 5756 |
17 |
| Pfizer Inc. | 3397 |
15 |
| AstraZeneca AB | 2857 |
12 |
| Daiichi Sankyo Company, Limited | 1878 |
12 |
| Nxera Pharma UK Limited | 172 |
12 |
| Takeda Pharmaceutical Company Limited | 2717 |
11 |
| Nurix Therapeutics, Inc. | 103 |
11 |
| Genentech, Inc. | 4008 |
10 |
| Glaxosmithkline Intellectual Property Development Limited | 770 |
10 |
| Teijin Limited | 1258 |
10 |
| Other owners | 589 |